Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 21, 2026
Advancing adoptive cellular immunotherapy via Notch-based ex vivo T cell development platformsAndrea Z Tuckett, Johannes L Zakrzewski
Journal of Visualized Experiments : Jove|September 12, 2022
A Minimally Invasive, Accurate, and Efficient Technique for Intrathymic Injection in MiceMichael T McGuire, Andrea Z Tuckett, Faith Myint, et al.
Investigational New Drugs|January 4, 2018
Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulationHsiu-Yu Liu, Andrea Z Tuckett, Myles Fennell, et al.
Ultrasound in Medicine & Biology|February 22, 2015
Free-hand ultrasound guidance permits safe and efficient minimally invasive intrathymic injections in both young and aged miceAndrea Z Tuckett, Johannes L Zakrzewski, Duan Li, et al.
Journal of Hematology & Oncology|May 18, 2017
Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiencyAndrea Z Tuckett, Raymond H Thornton, Richard J O'Reilly, et al.
Blood|March 22, 2014
Image-guided intrathymic injection of multipotent stem cells supports lifelong T-cell immunity and facilitates targeted immunotherapyAndrea Z Tuckett, Raymond H Thornton, Yusuke Shono, et al.
Cancer Research|January 9, 2016
Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress ResponsesYusuke Shono, Andrea Z Tuckett, Hsiou-Chi Liou, et al.
The Journal of Experimental Medicine|October 22, 2014
Sex steroid blockade enhances thymopoiesis by modulating Notch signalingEnrico Velardi, Jennifer J Tsai, Amanda M Holland, et al.
Cancer Discovery|February 20, 2014
A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activityYusuke Shono, Andrea Z Tuckett, Samedy Ouk, et al.
Nature Medicine|January 10, 2017
Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activityArnab Ghosh, Melody Smith, Scott E James, et al.
Pageof 1